Sleep Education for Insomnia in PTSD
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Since the study focuses on non-medication treatments, it's likely you can continue your current medications, but you should confirm with the study team.
What data supports the effectiveness of the treatment for insomnia in PTSD?
Research shows that cognitive behavioral therapy for insomnia (CBT-I) is effective in reducing insomnia severity and improving sleep quality. It has been successfully used in various formats, such as workshops and self-help programs, and is beneficial for people with PTSD who often experience sleep problems.12345
Is sleep education for insomnia in PTSD safe for humans?
How does the Sleep Education for Insomnia in PTSD treatment differ from other treatments for this condition?
This treatment is unique because it focuses on sleep education specifically tailored for individuals with PTSD, addressing both insomnia and trauma-related sleep disturbances. Unlike standard cognitive behavioral therapy for insomnia (CBT-I), it may incorporate elements like imagery rehearsal therapy (IRT) for nightmares, making it more comprehensive for PTSD-related sleep issues.24789
What is the purpose of this trial?
This pilot pre-post trial will address a gap in knowledge related to addressing modifiable risk factors for cardiometabolic disease through treating residual insomnia, sleep difficulties that remain after successful treatment of another condition, in the context of PTSD in understudied older adults. This study provides a non-medication treatment for PTSD called Cognitive Processing Therapy (CPT) followed by a non-medication sleep education and treatment program (Cognitive Behavioral Therapy for Insomnia, CBT-I) for sleep problems that remain after completing PTSD treatment in older adults with PTSD. The aims of this project are to evaluate 1) the added benefits of treating residual insomnia on sleep and PTSD symptoms; 2) the added benefits of treating residual insomnia following CPT on cardiometabolic risk biomarkers and quality of life; and 3) the durability of the sleep, PTSD, cardiometabolic and quality of life benefits of treating residual insomnia following CPT at 6-month follow-up in older adults with PTSD.
Research Team
Monica Kelly, PhD
Principal Investigator
UCLA / VA Greater Los Angeles
Eligibility Criteria
This trial is for Veterans aged 55+ with PTSD and insomnia, living within 50 miles of the VA Sepulveda Ambulatory Care Center. Participants must have used VHA services in the past year and be able to attend meetings. Those with severe diseases, unstable conditions, other sleep disorders or recent substance use recovery are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Evaluation
Participants complete baseline evaluations including health questionnaires, blood pressure monitoring, glucose monitoring, and sleep pattern assessments
PTSD Treatment
Participants receive Cognitive Processing Therapy (CPT) for PTSD
Sleep Education Program
Participants are randomly assigned to one of two sleep education programs to address residual insomnia
Follow-up
Participants are monitored for sleep, PTSD symptoms, cardiometabolic health, and quality of life
Treatment Details
Interventions
- Behavioral Sleep Education Intervention
- General Sleep Education Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
VA Office of Research and Development
Collaborator